V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002071 | 230008243 | 1.68 | 80.2 | null | 2020-05-19 | 2020-06-08 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100560032 |
| 230002073 | 230008244 | 1.67 | 75 | Palliative (P) | 2015-06-19 | 2017-04-07 | null | null | N | DOXORUBICIN | 100519661 |
| 230002075 | 230008246 | 1.62 | 68.4 | null | 2020-07-22 | 2020-08-03 | null | null | null | HYDROXYCARBAMIDE | 101208932 |
| 230002077 | 230008247 | 1.59 | 59 | null | 2017-05-18 | 2017-05-18 | null | null | null | BEVACIZUMAB | 101474197 |
| 230002078 | 230008248 | 1.57 | 78.7 | null | 2017-11-30 | 2017-12-30 | null | null | N | NAB-PACLITAXEL | 101221344 |
| 230002084 | 230008250 | 1.66 | 95 | null | 2018-07-02 | 2018-07-17 | Liposomal Doxorubicin 50mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 100495181 |
| 230002090 | 230008253 | null | null | Palliative (P) | null | 2021-05-04 | DOXORUBICIN | null | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101765445 |
| 230002091 | 230008254 | 1.52 | 67.1 | Palliative (P) | null | 2021-08-21 | null | null | null | PERTUZUMAB + TRASTUZUMAB | 100716171 |
| 230002092 | 230008255 | 1.58 | 93.6 | Palliative (P) | 2020-07-31 | 2020-11-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100758939 |
| 230002093 | 230008256 | 1.64 | 83.8 | null | 2017-07-12 | 2017-08-10 | DOXORUBICIN | 02 | null | TRIAL UNSPECIFIED | 101534372 |
| 230002094 | 230008257 | 1.71 | 83.2 | 02 | 2019-06-28 | 2019-09-09 | null | null | N | NAB-PACLITAXEL | 100577680 |
| 230002095 | 230008258 | null | null | Palliative (P) | 2020-05-17 | 2020-07-11 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100288931 |
| 230002096 | 230008259 | 1.64 | 61 | Palliative (P) | null | 2020-02-04 | null | 01 | N | PEMBROLIZUMAB | 100069176 |
| 230002097 | 230008260 | 1.51 | 53 | Palliative (P) | null | 2018-05-21 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100918154 |
| 230002099 | 230008262 | 1.66 | 76.4 | null | 2021-08-24 | 2021-08-25 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100874447 |
| 230002102 | 230008263 | 1.57 | 113.5 | null | 2019-11-17 | 2021-11-20 | null | null | null | NIVOLUMAB | 101463180 |
| 230002104 | 230008264 | 1.71 | 113 | Palliative (P) | 2018-02-06 | 2018-03-09 | null | 02 | N | CISPLATIN | 100649146 |
| 230002105 | 230008265 | null | null | null | null | 2021-07-24 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100862708 |
| 230002108 | 230008266 | 1.62 | 42.25 | Palliative (P) | 2020-09-12 | 2021-02-10 | null | null | N | PACLITAXEL | 100441467 |
| 230002109 | 230008267 | 1.69 | 54.6 | Palliative (P) | 2021-04-26 | 2021-04-28 | Niraparib | 02 | N | NIRAPARIB | 100812027 |
| 230002112 | 230008268 | 1.62 | 54 | Palliative (P) | 2017-10-28 | 2017-12-27 | Olaparib | 02 | N | OLAPARIB | 101610339 |
| 230002114 | 230008269 | 1.6 | 73.4 | null | 2020-07-19 | 2021-04-26 | ICON8B TRIAL | N | null | DOCETAXEL + GEMCITABINE | 101016107 |
| 230002117 | 230008272 | null | null | Palliative (P) | null | 2019-07-26 | null | null | N | TRIAL UNSPECIFIED | 100477391 |
| 230002121 | 230008273 | 1.58 | 51.2 | null | 2021-06-06 | 2021-07-26 | null | 02 | null | DOXORUBICIN | 100231171 |
| 230002124 | 230008275 | 1.74 | 68.8 | null | 2019-07-14 | 2020-07-04 | Niraparib | 02 | null | NIRAPARIB | 100318201 |
| 230002125 | 230008276 | 1.56 | 62.7 | Curative (C) | 2019-07-25 | 2019-07-27 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101100497 |
| 230002127 | 230008277 | 1.68 | 55.4 | null | 2020-08-14 | 2020-09-10 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101755948 |
| 230002128 | 230008278 | 1.47 | 41.1 | Palliative (P) | null | 2019-11-27 | PACLITAXEL | 02 | null | PACLITAXEL | 100303037 |
| 230002130 | 230008280 | 1.67 | 89.5 | null | 2020-12-17 | 2020-12-17 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100943287 |
| 230002131 | 230008281 | 1.72 | 48.4 | null | 2020-10-14 | 2020-10-14 | null | 02 | null | BEVACIZUMAB + CARBO + PACLITAXEL | 100061218 |
| 230002132 | 230008282 | 1.56 | 54 | null | 2020-05-06 | 2020-06-06 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101691266 |
| 230002133 | 230008283 | 1.52 | 54.9 | Palliative (P) | 2021-08-02 | 2021-08-03 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100173634 |
| 230002138 | 230008285 | null | null | null | 2020-07-01 | 2020-07-03 | Cisplatin + Radiotherapy | 02 | null | TRIAL UNSPECIFIED | 100730537 |
| 230002141 | 230008287 | 1.55 | 57.3 | Palliative (P) | 2021-11-25 | 2021-12-05 | null | null | N | BEVACIZUMAB | 101257171 |
| 230002143 | 230008288 | null | null | null | 2022-01-30 | 2022-02-19 | Paclitaxel (2 or 3 weekly) | 02 | null | PACLITAXEL | 100118813 |
| 230002144 | 230008289 | 1.68 | 58.8 | null | 2020-11-14 | 2020-12-02 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100159162 |
| 230002146 | 230008290 | 1.66 | 75 | null | 2021-10-16 | 2022-03-23 | null | null | null | TRIAL UNSPECIFIED | 100649868 |
| 230002150 | 230008292 | null | null | null | 2021-12-26 | 2022-01-11 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100633493 |
| 230002154 | 230008296 | 1.72 | 81.4 | Palliative (P) | 2021-02-23 | 2021-03-30 | null | 02 | N | IPILIMUMAB | 100565050 |
| 230002158 | 230008297 | 1.65 | 59.9 | Neo-adjuvant (N) | 2021-05-22 | 2021-06-02 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100331492 |
| 230002159 | 230008298 | 1.66 | 53.6 | null | null | 2019-08-11 | null | null | null | CARBOPLATIN + GEMCITABINE | 101786518 |
| 230002170 | 230008301 | 1.67 | 41 | null | 2019-08-27 | 2019-09-02 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100451950 |
| 230002172 | 230008302 | 1.64 | 73.1 | null | 2021-04-09 | 2021-07-22 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100755332 |
| 230002179 | 230008304 | 1.57 | 68 | null | 2021-06-02 | 2021-06-09 | Bevacizumab | 02 | null | BEVACIZUMAB | 100556662 |
| 230002180 | 230008305 | 1.57 | 55 | null | 2022-01-04 | 2022-01-04 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100470366 |
| 230002184 | 230008308 | null | null | null | null | 2020-02-09 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100731831 |
| 230002187 | 230008310 | 1.66 | 75.8 | Palliative (P) | null | 2019-07-25 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100767357 |
| 230002190 | 230008311 | 1.63 | 44.7 | null | 2021-11-29 | 2021-12-18 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101409364 |
| 230002191 | 230008312 | 1.74 | 80 | Palliative (P) | 2020-06-11 | 2020-06-15 | null | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101547711 |
| 230002192 | 230008313 | 1.58 | 119 | null | 2019-11-23 | 2019-12-08 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101733010 |